FAM
RXDX
Fred Alger Management’s Prometheus Biosciences, Inc. Common Stock RXDX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-1,331,759
| Closed | -$143M | – | 586 |
|
|
2023
Q1 | $143M | Sell |
1,331,759
-27,497
| -2% | -$2.95M | 0.76% | 24 |
|
|
2022
Q4 | $150M | Buy |
1,359,256
+323,091
| +31% | +$35.5M | 0.81% | 26 |
|
|
2022
Q3 | $61.1M | Buy |
1,036,165
+792,620
| +325% | +$46.8M | 0.31% | 94 |
|
|
2022
Q2 | $6.88M | Buy |
243,545
+110,787
| +83% | +$3.13M | 0.03% | 237 |
|
|
2022
Q1 | $5.01M | Sell |
132,758
-39,663
| -23% | -$1.5M | 0.02% | 270 |
|
|
2021
Q4 | $6.82M | Buy |
+172,421
| New | +$6.82M | 0.02% | 264 |
|